| |

Mesothelioma Surgery Debate: Experience is the Answer

6174132_technology

A pair of researchers in the UK say a cancer center’s level of experience in dealing with mesothelioma may be the most important factor in achieving good surgical outcomes – not which surgery is chosen.

Their new meta-analysis is the latest in a long line of studies attempting to discern which type of mesothelioma surgery is best for patients in terms of survival and complications. The global medical community remains sharply divided over the risks and benefits of lung-sparing pleurectomy/decortication vs. lung-removing extrapleural pneumonectomy.

In the newest study, authors Sotiris and Sayonara Papaspyros analyzed the results of 16 separate studies comparing P/D to EPP in the treatment of mesothelioma. They found a median survival range from 8.1 to 32 months with P/D while the longest median survival after EPP was 46.9 months and the shortest was 6.9.

The rate of complications with each types of mesothelioma surgery was also mixed: Complication rates ranged from as low as 5.9% with P/D and 10% with EPP to as high as 55% with P/D and 82.6% with EPP. The highest median mortality for P/D among the studies was 9.8% while the highest with EPP was 12.5%. But there were some studies where no mesothelioma patients died from P/D while the lowest death rate found with EPP was 3.2%.

In an effort to summarize these conflicting findings, the authors conclude that either surgery is sometimes warranted that that clinical experience appears to have the biggest impact on outcomes. “This systematic review suggests that surgery in the context of trimodality therapy offers acceptable perioperative outcomes and long-term survival. Centers specializing in malignant pleural mesothelioma management have better results,” they write in ISRN Surgery.

Because of the usual shape and tricky location of mesothelioma tumors – spread across the thin pleural lining that surrounds the lungs – both types of mesothelioma surgeries are considered extremely challenging and it is usually not possible to remove all traces of mesothelioma. For this reason, most centers combine mesothelioma surgery with chemotherapy and radiation before and/or after the procedure.

Source: Papaspyros, S and Papaspyros, S, “Surgical management of malignant pleural mesothelioma: Impact of surgery on survival and quality of life-relations to chemotherapy, radiotherapy, and alternative therapies”, February 2014, ISRN Surgery, http://www.hindawi.com/journals/isrn.surgery/2014/817203/

Similar Posts

  • | |

    Mesothelioma survivor Paul Kraus, alive and well 19 years after writing “Surviving Mesothelioma and Other Cancers

    Paul Kraus is considered the longest documented mesothelioma survivor in the world. He was diagnosed in 1997 with mesothelioma so widespread that he was given little hope of survival. Not willing to give up, he worked with a team of doctors to create his own tailored treatment protocol. This protocol included dramatic life style change, experimental therapies, dietary changes, mind-body medicine, and other modalities. Paul was fortunate. The protocol he and his doctors created helped him keep the mesothelioma in check. His book “Surviving Mesothelioma and Other Cancers: A Patient’s Guide” details his cancer voyage, the decisions he made, and his philosophies about health and healing. This book is now the best-selling mesothelioma book in the world and has inspired…

  • | |

    Doctors Describe "Concrete Therapeutic Approach" for Mesothelioma

    A team of medical researchers in Italy have achieved what they are calling “excellent” tumor control and survival results in malignant pleural mesothelioma patients using a combination of surgery, chemotherapy, and radiotherapy. Caused by exposure to asbestos, mesothelioma typically spreads quickly across the lung-encasing membrane called the pleura. There is no known cure but treatments are improving. In the current prospective study, 20 malignant pleural mesothelioma patients underwent radical pleurectomy/decortication followed by high doses of radiation. After surgeons removed as much of the visible mesothelioma tumor and surrounding tissue as possible, patients received 50Gy of radiation to the effected side of their chest, delivered in 25 fractions. Regions of particular concern for mesothelioma regrowth got an extra radiation “boost” to…

  • |

    Mesothelioma Still Rising Despite Ban in Ireland

    A study in Ireland confirms that it can take many years for a ban on asbestos to have a measurable impact on a country’s rates of malignant mesothelioma. Mesothelioma is the most serious of a list of diseases – including lung cancer, pleural plaques, asbestosis, and others – linked with exposure to asbestos dust. Affecting the linings around the lungs and other organs, mesothelioma is often resistant to most cancer treatments and may be fatal within a year of diagnosis. According to the International Ban Asbestos Secretariat, Ireland is one of 55 countries that have enacted some type of asbestos ban. However, although Ireland banned asbestos in 2000, a new study published in Cancer Epidemiology shows that incidence of the…

  • | |

    Does Radiotherapy Reduce Mesothelioma Pain?

    A new study says there is not enough evidence to support the use of radiotherapy for the treatment of pain associated with malignant pleural mesothelioma. Researchers at the University of Edinburgh in Scotland reviewed a range of past studies on mesothelioma pain and radiotherapy by searching databases that date back as far as 1974. To be eligible to be included in their review, the study had to focus on malignant pleural mesothelioma and radiotherapy given “with the intent of improving pain”. The study also had to report doses and fractionation of the radiotherapy and how the pain responded. In all, the researchers found eight studies on mesothelioma pain and radiotherapy that met the criteria. Two of the studies were prospective…

  • |

    Website Aims to Protect Homeowners from Mesothelioma

    Australia’s Cancer Council is trying to educate home renovators about their risk for mesothelioma with a new e-learning course. Australia has one of the highest per capita rates of mesothelioma in the world, largely because of several asbestos mining operations that were once located there. Although asbestos has been banned from building products in Australia since 1989, asbestos-linked diseases like mesothelioma, lung cancer, and asbestosis continue to pose a serious health concern. While mesothelioma has traditionally occurred among people exposed to asbestos on the job, Australia is now bracing for another “wave” of mesothelioma victims among homeowners who encounter asbestos while doing their own renovation projects. Cancer Council Australia has launched “kNOw asbestos in your home” in an effort to…

  • |

    Ape Virus Shrinks Mesothelioma Tumors in Lab

    A virus that causes leukemia in gibbon apes may have the power to help fight malignant mesothelioma in people. Gibbon ape leukemia virus (GALV) has been tested for years as a viral vector, a carrier of therapeutic genetic information, in the treatment of various human illnesses, including cancer. A new study in Japan compared GALV with a leukemia virus derived from mice to see which carrier communicated most efficiently with mesothelioma cells. While both types of viruses replicated in most of the mesothelioma cell lines tested, the mouse-derived virus was not effective in a mesothelioma cell line called ACC-MESO-1. In this cell line, only the GALV spread efficiently both in culture and in mice that had been given human mesothelioma…